MSMO1
Methylsterol monooxygenase 1
Also known as: DESP4, ERG25, MSMO1_HUMAN, SC4MOL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15800
- Gene
- MSMO1
- Ensembl
- ENSG00000052802
- Chromosome
- 4
- Canonical length
- 293 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
Sterol-C4-mehtyl oxidase-like protein was isolated based on its similarity to the yeast ERG25 protein. It contains a set of putative metal binding motifs with similarity to that seen in a family of membrane desaturases-hydroxylases. The protein is localized to the endoplasmic reticulum membrane and is believed to function in cholesterol biosynthesis. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
293 residues, UniProt reviewed canonical sequence.
>Q15800|MSMO1
1 MATNESVSIF SSASLAVEYV DSLLPENPLQ EPFKNAWNYM LNNYTKFQIA TWGSLIVHEA
61 LYFLFCLPGF LFQFIPYMKK YKIQKDKPET WENQWKCFKV LLFNHFCIQL PLICGTYYFT
121 EYFNIPYDWE RMPRWYFLLA RCFGCAVIED TWHYFLHRLL HHKRIYKYIH KVHHEFQAPF
181 GMEAEYAHPL ETLILGTGFF IGIVLLCDHV ILLWAWVTIR LLETIDVHSG YDIPLNPLNL
241 IPFYAGSRHH DFHHMNFIGN YASTFTWWDR IFGTDSQYNA YNEKRKKFEK KTELocalizationUniProt · AlphaFold · HPA
Whether an antibody against MSMO1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 538 nTPM
Expression across tissuesHPA
Tissue
- liver: 538 nTPM
- esophagus: 140 nTPM
- spinal cord: 108 nTPM
- adrenal gland: 93 nTPM
- epididymis: 92 nTPM
- cerebral cortex: 80 nTPM
Single-cell type
- epididymal principal cells: 1,438 nCPM
- esophageal apical cells: 981 nCPM
- breast lactating cells: 817 nCPM
- alveolar cells type 2: 526 nCPM
- esophageal suprabasal cells: 428 nCPM
- urothelial cells: 413 nCPM
Immune cell
- memory B-cell: 41 nTPM
- naive B-cell: 38 nTPM
- naive CD8 T-cell: 36 nTPM
- naive CD4 T-cell: 34 nTPM
- gdT-cell: 34 nTPM
- memory CD4 T-cell: 32 nTPM
Brain region
- medulla oblongata: 173 nTPM
- pons: 143 nTPM
- white matter: 106 nTPM
- hypothalamus: 105 nTPM
- midbrain: 103 nTPM
- thalamus: 81 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MSMO1.
Disease | AllUniProt
Conditions MSMO1 is implicated in, by any mechanism.
- Microcephaly, congenital cataract, and psoriasiform dermatitis (MCCPD) MIM:616834
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 92 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Microcephaly-congenital cataract-psoriasiform dermatitis syndrome
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.09
- gnomAD missense Z
- 0.59
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cholesterol biosynthetic process
- cholesterol biosynthetic process via lathosterol
- fatty acid metabolic process
- steroid metabolic process
- sterol biosynthetic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MSMO1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MSMO1 as an antibody target. Whether an autoantibody or antibody against MSMO1 could matter depends on whether native MSMO1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MSMO1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MSMO1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...